[HTML][HTML] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
M Niu, M Yi, N Li, S Luo, K Wu - Experimental hematology & oncology, 2021 - Springer
Immunotherapy, especially anti-programmed cell death protein 1/programmed cell death
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.
M Niu, M Yi, N Li, S Luo, K Wu - Experimental Hematology & Oncology, 2021 - go.gale.com
Immunotherapy, especially anti-programmed cell death protein 1/programmed cell death
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
[HTML][HTML] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
M Niu, M Yi, N Li, S Luo, K Wu - Experimental …, 2021 - ehoonline.biomedcentral.com
Immunotherapy, especially anti-programmed cell death protein 1/programmed cell death
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
[PDF][PDF] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
M Niu, M Yi, N Li, S Luo, K Wu - 2021 - scholar.archive.org
Immunotherapy, especially anti-programmed cell death protein 1/programmed cell death
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
M Niu, M Yi, N Li, S Luo, K Wu - Experimental Hematology & …, 2021 - search.proquest.com
Immunotherapy, especially anti-programmed cell death protein 1/programmed cell death
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
[HTML][HTML] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
M Niu, M Yi, N Li, S Luo, K Wu - Experimental Hematology & …, 2021 - ncbi.nlm.nih.gov
Immunotherapy, especially anti-programmed cell death protein 1/programmed cell death
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.
M Niu, M Yi, N Li, S Luo, K Wu - Experimental Hematology & …, 2021 - europepmc.org
Immunotherapy, especially anti-programmed cell death protein 1/programmed cell death
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
M Niu, M Yi, N Li, S Luo, K Wu - … hematology & oncology, 2021 - pubmed.ncbi.nlm.nih.gov
Immunotherapy, especially anti-programmed cell death protein 1/programmed cell death
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
[HTML][HTML] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
M Niu, M Yi, N Li, S Luo, K Wu - Experimental …, 2021 - ehoonline.biomedcentral.com
Immunotherapy, especially anti-programmed cell death protein 1/programmed cell death
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.
M Niu, M Yi, N Li, S Luo, K Wu - Experimental Hematology & …, 2021 - europepmc.org
Immunotherapy, especially anti-programmed cell death protein 1/programmed cell death
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …
ligand 1 (PD-1/PD-L1) treatment has significantly improved the survival of non-small cell …